Part 1
Part 2
We are excited to present a special 2 part episode of Allergytalk! Dr. Brian Vickery, the principal investigator of the PALISADE study that led to the first FDA-approved peanut immunotherapy, joins us to discuss his personal story and his thoughts on the future of food immunotherapy!
If you have a topic you’d like to cover in a future podcast, let us know at allergytalk@acaai.org.
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Dr. Lee
- Advisory board: Teva
Dr. Kuruvilla
- Nothing to disclose
Dr. Vickery
- Advisory board / consultant: Aimmune, AllerGenis, FARE and Reacta Biotech
- Site investigator: Aimmune, DBV, Genentech and Regeneron
- Research grants: FARE and NIAID
Episode 7 - Part 1 & 2
ACAAI presents this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to the procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that may be referenced.
